The Role of Vascular-Immune Interactions in Modulating Chemotherapy Induced Neuropathic Pain
Chemotherapy causes sensory disturbances in cancer patients that results in neuropathies and pain. As cancer survivorships has dramatically increased over the past 10 years, pain management of these patients is becoming clinically more important. Current analgesic strategies are mainly ineffective a...
Main Authors: | Tameille Valentine, Lydia Hardowar, Jasmine Elphick-Ross, Richard P. Hulse, Mark Paul-Clark |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.887608/full |
Similar Items
-
Neuropathic Itch
by: James Meixiong, et al.
Published: (2020-10-01) -
Soluble epoxide hydrolase inhibition alleviates chemotherapy induced neuropathic pain
by: Ashley A. Takeshita, et al.
Published: (2023-01-01) -
Topical phenytoin for the treatment of neuropathic pain
by: Kopsky DJ, et al.
Published: (2017-02-01) -
Editorial: Insights in neuropathic pain: 2022
by: Leyan Shan, et al.
Published: (2023-06-01) -
A mechanistic understanding of the relationship between skin innervation and chemotherapy-induced neuropathic pain
by: Cristina Meregalli, et al.
Published: (2022-12-01)